When professionals get it wrong, the consequences can range from awkward to genuinely alarming. This collection brings ...
Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is crucial for treatment planning. Systemic therapies, including combination ...
The Times of Israel on MSN
Despite ban, dozens still suffering kidney failure from toxic hair treatments
After two are hospitalized within weeks, doctor behind pioneering study on glyoxylic acid says straightening products still ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
Investigators reported extended 5-year follow-up data from the CheckMate 274 trial including exploratory MIBC and circulating tumor (ct)DNA data.
Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback